Patents for C12R 1 - Micro-organisms (92,025) |
---|
12/08/1994 | WO1994028134A1 Lymphocyte chemoattractant factor and uses thereof |
12/08/1994 | WO1994028132A2 Opioid receptors: compositions and methods |
12/08/1994 | WO1994028125A2 Dna encoding prostaglandin receptor ep1 |
12/08/1994 | WO1994028116A1 Nucleic acid encoding amp-activated protein kinase |
12/08/1994 | WO1994028027A1 Methods and materials for modulation of the immunosuppressive activity and toxicity of monoclonal antibodies |
12/08/1994 | WO1994028026A1 Genetically engineered immunoglobulins |
12/08/1994 | WO1994028016A1 CLONING, EXPRESSION AND USES OF $i(DORSALIN-1) |
12/08/1994 | WO1994027637A1 Monoclonal anti-idiotypic anti-ca125 antibodies and pharmaceutical compositions containing them |
12/08/1994 | WO1994027428A1 Post-transcriptional gene regulation by trace minerals |
12/08/1994 | WO1994027426A1 Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
12/08/1994 | WO1994016096A3 Method to predict active growth of bacteria adhered to a surface |
12/08/1994 | CA2698716A1 Cyclic gmp-binding, cyclic gmp-specific phosphodiesterase materials and methods |
12/08/1994 | CA2164428A1 Plasmodium vivax blood stage antigens, antibodies, and diagnostic assays |
12/08/1994 | CA2163790A1 Isolation of mushroom-inducing genes and their use in dna-mediated transformation of edible basidiomycetes |
12/08/1994 | CA2163620A1 Method for selection of biologically active peptide sequences |
12/08/1994 | CA2163549A1 Process for screening substances having a modulating effect on any interleukin-5 receptor mediated cellular signal transmission pathway |
12/08/1994 | CA2163515A1 Process for preparing glyoxylic acid/dialkyl aminomethylphosphonate mixtures |
12/08/1994 | CA2163438A1 Regulator of contact-mediated hemolysin |
12/08/1994 | CA2163427A1 Bifunctional selectable fusion genes based on the cytosine deaminase (cd) gene |
12/08/1994 | CA2163422A1 Antibodies specific for dcc gene product |
12/08/1994 | CA2163350A1 Opioid receptors: compositions and methods |
12/08/1994 | CA2163125A1 Genetically engineered immunoglobulins |
12/08/1994 | CA2162855A1 Expression of urokinase plasminogen activator inhibitors |
12/08/1994 | CA2162271A1 Fusion proteins containing adeno-associated virus rep protein and bacterial protein |
12/08/1994 | CA2161979A1 Cloning, expression and uses of dorsalin-1 |
12/08/1994 | CA2140527A1 Methods for increasing carbon conversion efficiency in microorganisms |
12/07/1994 | EP0627007A1 Process for the enzymatic oxidation of (d)-2-hydroxycarboxylic acids to 2-ketonic carboxylic acids |
12/07/1994 | EP0627005A1 Ibv spike protein (2) |
12/07/1994 | EP0627004A1 Improvements in or relating to malaria vaccine |
12/07/1994 | EP0627003A1 Stem cell inhibiting proteins |
12/07/1994 | EP0627002A1 Cloning and expression of humanized monoclonal antibodies against human interleukin-4 |
12/07/1994 | EP0627000A1 Mammalian expression systems for hcv proteins |
12/07/1994 | EP0578767A4 Alkaline protease 3733, its production and use in cleaning contact lens. |
12/07/1994 | EP0210189B1 Recombinant alveolar surfactant protein |
12/07/1994 | CN1026862C Process for producting of dry bioactive recombinant growth hormones |
12/06/1994 | US5371206 DNA encoding chimeric fibroblast growth factors |
12/06/1994 | US5371204 Interleukins |
12/06/1994 | US5371197 Protein-dimeric polysaccharide conjugate vaccine |
12/06/1994 | US5371017 Hepatitis C virus protease |
12/06/1994 | US5371013 Pure culture of Pseudomonas; can be used to prepare ferulic acid, vanillic acid, coniferyl alcohol and coniferyl aldehyde from eugenol |
12/06/1994 | US5371012 Fermentation product of psedomonas species ATCC 53923 is useful as an industrial thickening, suspending or stabilizing agents |
12/06/1994 | US5371009 Enhancers |
12/06/1994 | US5371006 Isolated DNA encoding the NotI restriction endonuclease and related methods for producing the same |
12/06/1994 | US5371000 Process for the production of ergoline derivatives |
12/06/1994 | US5370997 Hyperthermostable alpha-amylase |
12/06/1994 | US5370995 L-phenylalanyl-tRNA synthetase mutants, a process for the preparation thereof and the use thereof for the in vivo incorporation of non-proteinogenous amino acids into peptides or proteins |
12/06/1994 | US5370991 Cloned gene encoding human monocyte elastase inhibitor |
12/06/1994 | US5370990 Treating sample with protease, then with ketoamine oxidase obtained from Klebsiella, Fusarium, Acremonium or Debaryomyces microorganism, measuring hydrogen peroxide released |
12/06/1994 | CA1333368C Process for the production of a proteolytic complex enhancing pancreas activity and its applications in zootechnics |
12/01/1994 | DE4323754C1 New bifunctional urokinase derivs and related plasmids |
11/30/1994 | EP0626448A2 Process for preparing and purifying alpha-interferon |
11/30/1994 | EP0626447A1 Monoclonal antibodies and Fv specific for cd2 antigen |
11/30/1994 | EP0626390A1 Humanised antibodies |
11/30/1994 | EP0626389A1 Recombinant antibodies specific for TNF-alpha |
11/30/1994 | EP0625990A1 Glycoprotein complexes and glycoproteins |
11/30/1994 | EP0625989A1 Dna sequences encoding novel growth/differentiation factors |
11/30/1994 | EP0540556B1 Method of preparation of l-lysine-producing microorganisms |
11/30/1994 | EP0509008B1 Biomass for the production of viruses/virus antigens |
11/30/1994 | EP0436547B1 Process for rapid nucleic acid detection |
11/30/1994 | EP0424500B1 Novel cell wall lytic enzymes from bacillus pabuli |
11/29/1994 | US5369029 Method for degrading nucleic acids in waste fermentation solutions with Paecilomyces lilacinus |
11/29/1994 | US5369023 Method of purifying putrescine n-methyltransferase from tobacco plant extract with an anion exchange medium |
11/29/1994 | US5369021 Microorganism for selective production of a specific compound of avermectin and a method for selective production thereof |
11/29/1994 | US5369020 Method for suppressing coloring of human serum albumin |
11/29/1994 | US5368981 Method for increasing beta-tyrosinase activity in Erwinia herbicola |
11/29/1994 | CA1333264C Radiolabeled anti-platelet monoclonal antibody for imaging in-vivo thrombi |
11/27/1994 | CA2124271A1 Process for preparing and purifying alpha-interferon |
11/26/1994 | CA2124171A1 Process for preparing 2-amino-3-hydroxy acids |
11/26/1994 | CA2124170A1 Process for preparing serine hydroxymethyltransferase |
11/24/1994 | WO1994026926A1 Culture medium for rapid count of coliform bacteria |
11/24/1994 | WO1994026925A2 Processes for producing an enzyme |
11/24/1994 | WO1994026924A3 MONOCLONAL ANTIBODIES AGAINST THE α-TNF TYPE I RECEPTOR, PROCESS FOR THE PRODUCTION AND USE THEREOF |
11/24/1994 | WO1994026924A2 MONOCLONAL ANTIBODIES AGAINST THE α-TNF TYPE I RECEPTOR, PROCESS FOR THE PRODUCTION AND USE THEREOF |
11/24/1994 | WO1994026923A1 Method for recombinant production of biologically active polypeptides |
11/24/1994 | WO1994026918A1 Process for demethylating dimethylsulphonium compounds |
11/24/1994 | WO1994026915A1 Gene transfer into pancreatic and biliary epithelial cells |
11/24/1994 | WO1994026913A2 Marker gene |
11/24/1994 | WO1994026910A1 Immunotoxins comprising gelonin and an antibody |
11/24/1994 | WO1994026908A1 Cho cell sialidase by recombinant dna technology |
11/24/1994 | WO1994026906A2 CLONED DNA ENCODING A UDP-GALNAc:POLYPEPTIDE,N-ACETYLGALACTOS AMINYLTRANSFERASE |
11/24/1994 | WO1994026893A1 Bmp-10 compositions |
11/24/1994 | WO1994026892A1 Bmp-11 compositions |
11/24/1994 | WO1994026891A2 Purified mammalian flt3 ligands and agonists and antagonists thereof |
11/24/1994 | WO1994026882A1 Proline iminopeptidase, process for its preparation and its use in the flavouring of food compositions |
11/24/1994 | WO1994026880A1 Combined action of endoglucanases and cellobiohydrolases |
11/24/1994 | WO1994026879A1 CLONING AND EXPRESSION OF THE GENE OF THE MALOLACTIC ENZYME OF $i(LACTOCOCCUS LACTIS) |
11/24/1994 | WO1994026877A1 Ribozyme gene therapy for hiv infection and aids |
11/24/1994 | WO1994026873A1 Yeast strain and methods for expressing heterologous proteins in yeast |
11/24/1994 | WO1994026784A1 Composition of antibodies against hepatitis b surface antigen |
11/24/1994 | WO1994026782A1 PSEUDOMONAS SYRINGAE pv. SYRINGAE hrpZ GENE |
11/24/1994 | WO1994026781A1 Thermoresistant alpha-1-antitrypsin mutein |
11/24/1994 | WO1994026308A1 A method to prevent side effects and insensitivity to the therapeutic uses of toxins |
11/24/1994 | WO1994026304A1 Otitis media vaccine |
11/24/1994 | WO1994026284A1 Use of modified tall-104 cells to treat cancer and viral diseases |
11/24/1994 | WO1994023034A3 Variant insulin-like growth factor I receptor subunits and methods for use thereof |
11/24/1994 | WO1994019472A3 Bi-functional expression system |
11/24/1994 | WO1994019466A3 A novel family of anti-carcinoembryonic antigen chimeric antibodies |
11/24/1994 | WO1994019464A3 Human dna sequence encoding a kidney atp-dependent potassium channel |
11/24/1994 | WO1994016073A3 Methods and reagents for inhibiting furin endoprotease |
11/24/1994 | CA2163129A1 Ribozyme gene therapy for hiv infection and aids |